TSS
AKYA

Two Sigma Securities’s Akoya BioSciences AKYA Stock Holding History

Two Sigma Securities’s Portfolio AKYA Stock Details AKYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-11,087
Closed -$30.2K – 1624
2024
Q3 		$30.2K Buy
+11,087
New +$27.1K ﹤0.01% 2433

Other funds holding AKYA

BWLSA
Blue Water Life Science Advisors Larkspur, California $125M AUM 91.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAPAIJV
Paragon Associates & Paragon Associates II Joint Venture Dallas, Texas $73.6M AUM 61.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SW
SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PCA
Peddock Capital Advisors Braintree, Massachusetts $501M AUM 29.8% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Two Sigma Securities's AKYA Position: Q4 2024 in Review

Two Sigma Securities sold out of Akoya BioSciences (AKYA) in Q4 2024, closing a stake of 11,087 shares — an estimated $30.2K sold.

Two Sigma Securities first reported a position in AKYA in Q3 2024 and held it in 1 quarter. The position peaked at $30.2K in Q3 2024. 61 funds tracked by Wall St. Rank hold AKYA as of Q4 2024.

  • Two Sigma Securities reported no remaining Akoya BioSciences position as of Q4 2024 after selling out during the quarter.
  • Two Sigma Securities sold 11,087 Akoya BioSciences shares in Q4 2024, an estimated $30.2K.
  • Two Sigma Securities first reported a position in Akoya BioSciences in Q3 2024 and held it in 1 quarter.
  • Two Sigma Securities's Akoya BioSciences position peaked at $30.2K in Q3 2024.
  • 61 funds tracked by Wall St. Rank held Akoya BioSciences as of Q4 2024.

Based on Two Sigma Securities's 13F filing for Q4 2024, filed 14 Feb 2025.